CTS 2026: What to Expect in Las Vegas

Arshad M. Khanani, MD, previews this year’s Clinical Trials at the Summit meeting, highlighting new clinical trial data, expert panels discussing a variety of topics, and a keynote by the former director of the FDA’s ophthalmic devices division.

By: Arshad M. Khanani, MD, MA, FASRS

Retinal Physician June 4, 2026

Clinical Scorecard: CTS 2026: What to Expect in Las Vegas

At a Glance

Category	Detail
Condition
Key Mechanisms
Target Population	Ophthalmic professionals and clinical trialists
Care Setting	Clinical Trials at the Summit meeting

Key Highlights

139 program participants with approximately 90 presentations
First-time results from phase 2 and phase 3 trials
Panels on artificial intelligence in retinal clinical trials
Keynote lecture by Wiley A. Chambers, MD
Annual awards: Summit of Excellence for industry and physician, Ascent to Excellence for an up-and-coming clinical trialist

Guideline-Based Recommendations

Diagnosis

Management

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Not specified

Clinical Best Practices

Related Resources & Content

Clinical Trials at the Summit

PentaVision

Retinal Physician